International Wound Journal-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2233025, encodeId=ea4f2233025cc, content=被 on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:48:17 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2203502, encodeId=74042203502fb, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=冲冲冲h, createdTime=Wed May 08 18:20:24 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195170, encodeId=895e21951e056, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：皮肤;黑色素瘤 经验分享：想问一下投稿的大伙，纯生信（转录组测序的）可以投吗，皮肤方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3c2456097, createdName=liebe9494, createdTime=Mon Mar 25 10:57:47 CST 2024, time=2024-03-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1182634, encodeId=3c59118263488, content=请问pending decision一般会多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7cc5323315, createdName=148b29a2m24暂无昵称, createdTime=Sun Jan 09 21:58:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145934, encodeId=5ddb2145934ea, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：稿件主题糖尿病足量表汉化，未修主编直接决定录用，版面费24000+，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0pWgm3w1NrBtdH44O8xxxA&s=100, createdBy=48292561609, createdName=ms8659770673755343, createdTime=Sun Jul 02 09:35:49 CST 2023, time=2023-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240289, encodeId=6a65124028920, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：投稿到接受1个多月，无审稿费，但是版面费很贵，3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Mon Aug 22 16:12:31 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139139, encodeId=d81a213913953, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：大约两个月左右就收了，中间没有修改，没有审稿费，版面费3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Fri May 26 10:43:38 CST 2023, time=2023-05-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1206243, encodeId=e61d12062436d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：量表汉化;压疮 经验分享：投稿日期：2022年01月31日 接收日期：2022年03月14日 直接接收，可能比较幸运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5975510070, createdName=ms6000002050051022, createdTime=Sat Mar 26 22:27:48 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534944, encodeId=3dbc5349448b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：拒絕極快速 還算是友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:11:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187003, encodeId=5650118e003ca, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2532.0 经验分享：审稿意见较为平和，一次小修过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2e75422150, createdName=ms5000002027922659, createdTime=Fri Jan 21 22:21:51 CST 2022, time=2022-01-21, status=1, ipAttribution=)]

2024-10-25 侠胆医心来自威斯康星

被 on hold了

37 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233025, encodeId=ea4f2233025cc, content=被 on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:48:17 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2203502, encodeId=74042203502fb, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=冲冲冲h, createdTime=Wed May 08 18:20:24 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195170, encodeId=895e21951e056, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：皮肤;黑色素瘤 经验分享：想问一下投稿的大伙，纯生信（转录组测序的）可以投吗，皮肤方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3c2456097, createdName=liebe9494, createdTime=Mon Mar 25 10:57:47 CST 2024, time=2024-03-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1182634, encodeId=3c59118263488, content=请问pending decision一般会多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7cc5323315, createdName=148b29a2m24暂无昵称, createdTime=Sun Jan 09 21:58:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145934, encodeId=5ddb2145934ea, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：稿件主题糖尿病足量表汉化，未修主编直接决定录用，版面费24000+，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0pWgm3w1NrBtdH44O8xxxA&s=100, createdBy=48292561609, createdName=ms8659770673755343, createdTime=Sun Jul 02 09:35:49 CST 2023, time=2023-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240289, encodeId=6a65124028920, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：投稿到接受1个多月，无审稿费，但是版面费很贵，3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Mon Aug 22 16:12:31 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139139, encodeId=d81a213913953, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：大约两个月左右就收了，中间没有修改，没有审稿费，版面费3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Fri May 26 10:43:38 CST 2023, time=2023-05-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1206243, encodeId=e61d12062436d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：量表汉化;压疮 经验分享：投稿日期：2022年01月31日 接收日期：2022年03月14日 直接接收，可能比较幸运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5975510070, createdName=ms6000002050051022, createdTime=Sat Mar 26 22:27:48 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534944, encodeId=3dbc5349448b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：拒絕極快速 還算是友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:11:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187003, encodeId=5650118e003ca, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2532.0 经验分享：审稿意见较为平和，一次小修过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2e75422150, createdName=ms5000002027922659, createdTime=Fri Jan 21 22:21:51 CST 2022, time=2022-01-21, status=1, ipAttribution=)]

2024-05-08 冲冲冲h 来自广东省

审稿速度:24.0 | 投稿命中率:5.0
经验分享：被on hold了

93 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233025, encodeId=ea4f2233025cc, content=被 on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:48:17 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2203502, encodeId=74042203502fb, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=冲冲冲h, createdTime=Wed May 08 18:20:24 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195170, encodeId=895e21951e056, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：皮肤;黑色素瘤 经验分享：想问一下投稿的大伙，纯生信（转录组测序的）可以投吗，皮肤方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3c2456097, createdName=liebe9494, createdTime=Mon Mar 25 10:57:47 CST 2024, time=2024-03-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1182634, encodeId=3c59118263488, content=请问pending decision一般会多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7cc5323315, createdName=148b29a2m24暂无昵称, createdTime=Sun Jan 09 21:58:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145934, encodeId=5ddb2145934ea, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：稿件主题糖尿病足量表汉化，未修主编直接决定录用，版面费24000+，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0pWgm3w1NrBtdH44O8xxxA&s=100, createdBy=48292561609, createdName=ms8659770673755343, createdTime=Sun Jul 02 09:35:49 CST 2023, time=2023-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240289, encodeId=6a65124028920, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：投稿到接受1个多月，无审稿费，但是版面费很贵，3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Mon Aug 22 16:12:31 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139139, encodeId=d81a213913953, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：大约两个月左右就收了，中间没有修改，没有审稿费，版面费3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Fri May 26 10:43:38 CST 2023, time=2023-05-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1206243, encodeId=e61d12062436d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：量表汉化;压疮 经验分享：投稿日期：2022年01月31日 接收日期：2022年03月14日 直接接收，可能比较幸运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5975510070, createdName=ms6000002050051022, createdTime=Sat Mar 26 22:27:48 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534944, encodeId=3dbc5349448b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：拒絕極快速 還算是友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:11:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187003, encodeId=5650118e003ca, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2532.0 经验分享：审稿意见较为平和，一次小修过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2e75422150, createdName=ms5000002027922659, createdTime=Fri Jan 21 22:21:51 CST 2022, time=2022-01-21, status=1, ipAttribution=)]

2024-03-25 liebe9494 来自上海

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：皮肤;黑色素瘤
经验分享：想问一下投稿的大伙，纯生信（转录组测序的）可以投吗，皮肤方向的

94 0

[GetPortalCommentsPageByObjectIdResponse(id=2233025, encodeId=ea4f2233025cc, content=被 on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:48:17 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2203502, encodeId=74042203502fb, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=冲冲冲h, createdTime=Wed May 08 18:20:24 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195170, encodeId=895e21951e056, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：皮肤;黑色素瘤 经验分享：想问一下投稿的大伙，纯生信（转录组测序的）可以投吗，皮肤方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3c2456097, createdName=liebe9494, createdTime=Mon Mar 25 10:57:47 CST 2024, time=2024-03-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1182634, encodeId=3c59118263488, content=请问pending decision一般会多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7cc5323315, createdName=148b29a2m24暂无昵称, createdTime=Sun Jan 09 21:58:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145934, encodeId=5ddb2145934ea, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：稿件主题糖尿病足量表汉化，未修主编直接决定录用，版面费24000+，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0pWgm3w1NrBtdH44O8xxxA&s=100, createdBy=48292561609, createdName=ms8659770673755343, createdTime=Sun Jul 02 09:35:49 CST 2023, time=2023-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240289, encodeId=6a65124028920, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：投稿到接受1个多月，无审稿费，但是版面费很贵，3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Mon Aug 22 16:12:31 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139139, encodeId=d81a213913953, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：大约两个月左右就收了，中间没有修改，没有审稿费，版面费3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Fri May 26 10:43:38 CST 2023, time=2023-05-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1206243, encodeId=e61d12062436d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：量表汉化;压疮 经验分享：投稿日期：2022年01月31日 接收日期：2022年03月14日 直接接收，可能比较幸运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5975510070, createdName=ms6000002050051022, createdTime=Sat Mar 26 22:27:48 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534944, encodeId=3dbc5349448b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：拒絕極快速 還算是友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:11:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187003, encodeId=5650118e003ca, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2532.0 经验分享：审稿意见较为平和，一次小修过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2e75422150, createdName=ms5000002027922659, createdTime=Fri Jan 21 22:21:51 CST 2022, time=2022-01-21, status=1, ipAttribution=)]

2022-01-09 148b29a2m24暂无昵称

请问pending decision一般会多久

159 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233025, encodeId=ea4f2233025cc, content=被 on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:48:17 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2203502, encodeId=74042203502fb, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=冲冲冲h, createdTime=Wed May 08 18:20:24 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195170, encodeId=895e21951e056, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：皮肤;黑色素瘤 经验分享：想问一下投稿的大伙，纯生信（转录组测序的）可以投吗，皮肤方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3c2456097, createdName=liebe9494, createdTime=Mon Mar 25 10:57:47 CST 2024, time=2024-03-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1182634, encodeId=3c59118263488, content=请问pending decision一般会多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7cc5323315, createdName=148b29a2m24暂无昵称, createdTime=Sun Jan 09 21:58:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145934, encodeId=5ddb2145934ea, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：稿件主题糖尿病足量表汉化，未修主编直接决定录用，版面费24000+，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0pWgm3w1NrBtdH44O8xxxA&s=100, createdBy=48292561609, createdName=ms8659770673755343, createdTime=Sun Jul 02 09:35:49 CST 2023, time=2023-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240289, encodeId=6a65124028920, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：投稿到接受1个多月，无审稿费，但是版面费很贵，3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Mon Aug 22 16:12:31 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139139, encodeId=d81a213913953, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：大约两个月左右就收了，中间没有修改，没有审稿费，版面费3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Fri May 26 10:43:38 CST 2023, time=2023-05-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1206243, encodeId=e61d12062436d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：量表汉化;压疮 经验分享：投稿日期：2022年01月31日 接收日期：2022年03月14日 直接接收，可能比较幸运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5975510070, createdName=ms6000002050051022, createdTime=Sat Mar 26 22:27:48 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534944, encodeId=3dbc5349448b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：拒絕極快速 還算是友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:11:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187003, encodeId=5650118e003ca, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2532.0 经验分享：审稿意见较为平和，一次小修过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2e75422150, createdName=ms5000002027922659, createdTime=Fri Jan 21 22:21:51 CST 2022, time=2022-01-21, status=1, ipAttribution=)]

2023-07-02 ms8659770673755343 来自广东省

审稿速度:2.0 | 投稿命中率:95.0
经验分享：稿件主题糖尿病足量表汉化，未修主编直接决定录用，版面费24000+，

136 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233025, encodeId=ea4f2233025cc, content=被 on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:48:17 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2203502, encodeId=74042203502fb, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=冲冲冲h, createdTime=Wed May 08 18:20:24 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195170, encodeId=895e21951e056, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：皮肤;黑色素瘤 经验分享：想问一下投稿的大伙，纯生信（转录组测序的）可以投吗，皮肤方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3c2456097, createdName=liebe9494, createdTime=Mon Mar 25 10:57:47 CST 2024, time=2024-03-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1182634, encodeId=3c59118263488, content=请问pending decision一般会多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7cc5323315, createdName=148b29a2m24暂无昵称, createdTime=Sun Jan 09 21:58:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145934, encodeId=5ddb2145934ea, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：稿件主题糖尿病足量表汉化，未修主编直接决定录用，版面费24000+，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0pWgm3w1NrBtdH44O8xxxA&s=100, createdBy=48292561609, createdName=ms8659770673755343, createdTime=Sun Jul 02 09:35:49 CST 2023, time=2023-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240289, encodeId=6a65124028920, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：投稿到接受1个多月，无审稿费，但是版面费很贵，3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Mon Aug 22 16:12:31 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139139, encodeId=d81a213913953, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：大约两个月左右就收了，中间没有修改，没有审稿费，版面费3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Fri May 26 10:43:38 CST 2023, time=2023-05-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1206243, encodeId=e61d12062436d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：量表汉化;压疮 经验分享：投稿日期：2022年01月31日 接收日期：2022年03月14日 直接接收，可能比较幸运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5975510070, createdName=ms6000002050051022, createdTime=Sat Mar 26 22:27:48 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534944, encodeId=3dbc5349448b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：拒絕極快速 還算是友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:11:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187003, encodeId=5650118e003ca, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2532.0 经验分享：审稿意见较为平和，一次小修过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2e75422150, createdName=ms5000002027922659, createdTime=Fri Jan 21 22:21:51 CST 2022, time=2022-01-21, status=1, ipAttribution=)]

2022-08-22 190374007

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：TLIF;感染;糖尿病
经验分享：投稿到接受1个多月，无审稿费，但是版面费很贵，3100美元

169 0

[GetPortalCommentsPageByObjectIdResponse(id=2233025, encodeId=ea4f2233025cc, content=被 on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:48:17 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2203502, encodeId=74042203502fb, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=冲冲冲h, createdTime=Wed May 08 18:20:24 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195170, encodeId=895e21951e056, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：皮肤;黑色素瘤 经验分享：想问一下投稿的大伙，纯生信（转录组测序的）可以投吗，皮肤方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3c2456097, createdName=liebe9494, createdTime=Mon Mar 25 10:57:47 CST 2024, time=2024-03-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1182634, encodeId=3c59118263488, content=请问pending decision一般会多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7cc5323315, createdName=148b29a2m24暂无昵称, createdTime=Sun Jan 09 21:58:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145934, encodeId=5ddb2145934ea, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：稿件主题糖尿病足量表汉化，未修主编直接决定录用，版面费24000+，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0pWgm3w1NrBtdH44O8xxxA&s=100, createdBy=48292561609, createdName=ms8659770673755343, createdTime=Sun Jul 02 09:35:49 CST 2023, time=2023-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240289, encodeId=6a65124028920, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：投稿到接受1个多月，无审稿费，但是版面费很贵，3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Mon Aug 22 16:12:31 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139139, encodeId=d81a213913953, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：大约两个月左右就收了，中间没有修改，没有审稿费，版面费3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Fri May 26 10:43:38 CST 2023, time=2023-05-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1206243, encodeId=e61d12062436d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：量表汉化;压疮 经验分享：投稿日期：2022年01月31日 接收日期：2022年03月14日 直接接收，可能比较幸运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5975510070, createdName=ms6000002050051022, createdTime=Sat Mar 26 22:27:48 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534944, encodeId=3dbc5349448b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：拒絕極快速 還算是友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:11:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187003, encodeId=5650118e003ca, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2532.0 经验分享：审稿意见较为平和，一次小修过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2e75422150, createdName=ms5000002027922659, createdTime=Fri Jan 21 22:21:51 CST 2022, time=2022-01-21, status=1, ipAttribution=)]

2023-05-26 190374007 来自江苏省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：TLIF;感染;糖尿病
经验分享：大约两个月左右就收了，中间没有修改，没有审稿费，版面费3100美元

216 0

[GetPortalCommentsPageByObjectIdResponse(id=2233025, encodeId=ea4f2233025cc, content=被 on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:48:17 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2203502, encodeId=74042203502fb, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=冲冲冲h, createdTime=Wed May 08 18:20:24 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195170, encodeId=895e21951e056, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：皮肤;黑色素瘤 经验分享：想问一下投稿的大伙，纯生信（转录组测序的）可以投吗，皮肤方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3c2456097, createdName=liebe9494, createdTime=Mon Mar 25 10:57:47 CST 2024, time=2024-03-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1182634, encodeId=3c59118263488, content=请问pending decision一般会多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7cc5323315, createdName=148b29a2m24暂无昵称, createdTime=Sun Jan 09 21:58:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145934, encodeId=5ddb2145934ea, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：稿件主题糖尿病足量表汉化，未修主编直接决定录用，版面费24000+，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0pWgm3w1NrBtdH44O8xxxA&s=100, createdBy=48292561609, createdName=ms8659770673755343, createdTime=Sun Jul 02 09:35:49 CST 2023, time=2023-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240289, encodeId=6a65124028920, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：投稿到接受1个多月，无审稿费，但是版面费很贵，3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Mon Aug 22 16:12:31 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139139, encodeId=d81a213913953, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：大约两个月左右就收了，中间没有修改，没有审稿费，版面费3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Fri May 26 10:43:38 CST 2023, time=2023-05-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1206243, encodeId=e61d12062436d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：量表汉化;压疮 经验分享：投稿日期：2022年01月31日 接收日期：2022年03月14日 直接接收，可能比较幸运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5975510070, createdName=ms6000002050051022, createdTime=Sat Mar 26 22:27:48 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534944, encodeId=3dbc5349448b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：拒絕極快速 還算是友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:11:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187003, encodeId=5650118e003ca, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2532.0 经验分享：审稿意见较为平和，一次小修过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2e75422150, createdName=ms5000002027922659, createdTime=Fri Jan 21 22:21:51 CST 2022, time=2022-01-21, status=1, ipAttribution=)]

2022-03-26 ms6000002050051022

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：量表汉化;压疮
经验分享：投稿日期：2022年01月31日
接收日期：2022年03月14日

直接接收，可能比较幸运吧

190 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233025, encodeId=ea4f2233025cc, content=被 on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:48:17 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2203502, encodeId=74042203502fb, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=冲冲冲h, createdTime=Wed May 08 18:20:24 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195170, encodeId=895e21951e056, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：皮肤;黑色素瘤 经验分享：想问一下投稿的大伙，纯生信（转录组测序的）可以投吗，皮肤方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3c2456097, createdName=liebe9494, createdTime=Mon Mar 25 10:57:47 CST 2024, time=2024-03-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1182634, encodeId=3c59118263488, content=请问pending decision一般会多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7cc5323315, createdName=148b29a2m24暂无昵称, createdTime=Sun Jan 09 21:58:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145934, encodeId=5ddb2145934ea, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：稿件主题糖尿病足量表汉化，未修主编直接决定录用，版面费24000+，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0pWgm3w1NrBtdH44O8xxxA&s=100, createdBy=48292561609, createdName=ms8659770673755343, createdTime=Sun Jul 02 09:35:49 CST 2023, time=2023-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240289, encodeId=6a65124028920, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：投稿到接受1个多月，无审稿费，但是版面费很贵，3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Mon Aug 22 16:12:31 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139139, encodeId=d81a213913953, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：大约两个月左右就收了，中间没有修改，没有审稿费，版面费3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Fri May 26 10:43:38 CST 2023, time=2023-05-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1206243, encodeId=e61d12062436d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：量表汉化;压疮 经验分享：投稿日期：2022年01月31日 接收日期：2022年03月14日 直接接收，可能比较幸运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5975510070, createdName=ms6000002050051022, createdTime=Sat Mar 26 22:27:48 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534944, encodeId=3dbc5349448b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：拒絕極快速 還算是友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:11:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187003, encodeId=5650118e003ca, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2532.0 经验分享：审稿意见较为平和，一次小修过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2e75422150, createdName=ms5000002027922659, createdTime=Fri Jan 21 22:21:51 CST 2022, time=2022-01-21, status=1, ipAttribution=)]

2017-03-31 proflin

审稿速度:2.0 | 投稿命中率:50.0
经验分享：拒絕極快速
還算是友善

334 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233025, encodeId=ea4f2233025cc, content=被 on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:48:17 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2203502, encodeId=74042203502fb, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：被on hold了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=冲冲冲h, createdTime=Wed May 08 18:20:24 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195170, encodeId=895e21951e056, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：皮肤;黑色素瘤 经验分享：想问一下投稿的大伙，纯生信（转录组测序的）可以投吗，皮肤方向的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a3c2456097, createdName=liebe9494, createdTime=Mon Mar 25 10:57:47 CST 2024, time=2024-03-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1182634, encodeId=3c59118263488, content=请问pending decision一般会多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7cc5323315, createdName=148b29a2m24暂无昵称, createdTime=Sun Jan 09 21:58:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145934, encodeId=5ddb2145934ea, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：稿件主题糖尿病足量表汉化，未修主编直接决定录用，版面费24000+，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0pWgm3w1NrBtdH44O8xxxA&s=100, createdBy=48292561609, createdName=ms8659770673755343, createdTime=Sun Jul 02 09:35:49 CST 2023, time=2023-07-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240289, encodeId=6a65124028920, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：投稿到接受1个多月，无审稿费，但是版面费很贵，3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Mon Aug 22 16:12:31 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139139, encodeId=d81a213913953, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：TLIF;感染;糖尿病 经验分享：大约两个月左右就收了，中间没有修改，没有审稿费，版面费3100美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Fri May 26 10:43:38 CST 2023, time=2023-05-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1206243, encodeId=e61d12062436d, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：量表汉化;压疮 经验分享：投稿日期：2022年01月31日 接收日期：2022年03月14日 直接接收，可能比较幸运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5975510070, createdName=ms6000002050051022, createdTime=Sat Mar 26 22:27:48 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534944, encodeId=3dbc5349448b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：拒絕極快速 還算是友善, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:11:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187003, encodeId=5650118e003ca, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2532.0 经验分享：审稿意见较为平和，一次小修过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2e75422150, createdName=ms5000002027922659, createdTime=Fri Jan 21 22:21:51 CST 2022, time=2022-01-21, status=1, ipAttribution=)]

2022-01-21 ms5000002027922659

审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2532.0
经验分享：审稿意见较为平和，一次小修过

175 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务